Abstract:Obsessive Compulsive Disorder (OCD) is a debilitating psychiatric disorder characterized by intrusive obsessive thoughts and compulsive behaviors. Multiple studies have shown association of polymorphisms in the SLC1A1 gene with OCD. The most common of these OCD-associated polymorphisms increases expression of the encoded protein, Excitatory Amino Acid Transporter 3 (EAAT3), a neuronal glutamate transporter. Previous work has shown that increased EAAT3 expression results in OCD-relevant behavioral phenotypes in rodent models. In this study, we created a novel mouse model with targeted, reversible overexpression of Slc1a1 in forebrain neurons. These mice do not have a baseline difference in repetitive behavior but show increased hyperlocomotion following a low dose of amphetamine (3 mg/kg) and increased stereotypy following a high dose of amphetamine (8 mg/kg). We next characterized the effect of amphetamine on striatal cFos response and found that amphetamine increased cFos throughout the striatum in both control and Slc1a1 -overexpressing (OE) mice, but Slc1a1 -OE mice had increased cFos expression in the ventral striatum relative to controls. We used an unbiased machine classifier to robustly characterize the behavioral response to different doses of amphetamine and found a unique response to amphetamine in Slc1a1 -OE mice, relative to controls. Lastly, we found that the differences in striatal cFos expression in Slc1a1 -OE mice were driven by cFos expression specifically in D1 neurons, as Slc1a1 -OE mice had increased cFos in D1 ventral medial striatal neurons, implicating this region in the exaggerated behavioral response to amphetamine in Slc1a1 -OE mice. Significance statement Obsessive compulsive disorder is a debilitating psychiatric disorder with inadequate treatment options. The gene SLC1A1 has been associated with OCD in humans, and studies in rodents have shown alterations in OCD-relevant behavior and neural activity in mice with increased Slc1a1 expression. We created a novel mouse model with reversible forebrain overexpression of Slc1a1 and found that these mice show increased behavioral response to amphetamine. Using an unbiased machine classifier we found differences in clusters of amphetamine-induced behaviors in Slc1a1 -overexpressing mice. In addition, Slc1a1 -overexpressing mice showed increased neuronal activation in D1-expressing cells in ventromedial striatum following amphetamine administration. These results provide information about the role of Slc1a1 in repetitive behaviors and may contribute to novel treatments going forward.

Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice

Forebrain EAAT3 overexpression increases susceptibility to amphetamine-induced repetitive behaviors

Increased forebrain EAAT3 expression confers resilience to chronic stress

Intact amphetamine-induced behavioral sensitization in mice with increased or decreased neuronal glutamate transporter SLC1A1/EAAT3

Amphetamine-Induced OCD-Related Repetitive Behaviors Are Potentiated in Slc1a1-OE Mice

Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder

Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy

Cortical Glutamate and GABA Are Related to Compulsive Behaviour in Individuals with Obsessive Compulsive Disorder and Healthy Controls

OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons

Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

Differentially Expressed Genes of the Slc6a Family as Markers of Altered Brain Neurotransmitter System Function in Pathological States in Mice

Neurobehavioral and Neurochemical Basis of Compulsive Behavior: A 7T Magnetic Resonance Spectroscopy Study in Humans

Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine

Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.

Deletion of Murine Astrocytic Vesicular Nucleotide Transporter Increases Anxiety and Depressive-Like Behavior and Attenuates Motivation for Reward

GLS1 Mutant Mice Display Moderate Alterations of Hippocampal Glutamatergic Neurotransmission Associated with Specific Adaptive Behavioral Changes

Association of rs11081062 polymorphism of DLGAP1 gene and levels of SLC1A1 protein with obsessive-compulsive disorder

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice

Integrating Evolutionary and Regulatory Information with a Multispecies Approach Implicates Genes and Pathways in Obsessive-Compulsive Disorder

Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.

The Role of Vesicular Glutamate Transporter Type 3 in Social Behavior, with a Focus on the Median Raphe Region